Dr. Rose Thiessen represents individual and business clients in patent prosecution and licensing for chemical, pharmaceutical, medical device, and other life science technologies. Rose’s practice includes patent portfolio management and filing strategies in the U.S. and abroad, client counseling on issues related to licensing, infringement and trade secrets, and intellectual property due diligence in conjunction with financing, partnerships, acquisitions, and IPOs.
With nearly two decades of practice, Rose has proven successful time and again in helping new and emerging companies build, expand and fortify their IP portfolios and patent families. She knows how to capture even the most complex inventions in a way that allows her client the flexibility to pursue variations down the road. As a result, Rose’s clients have benefitted from her well-crafted applications in order to cover new embodiments over time. Rose’s counsel is grounded in seeing each matter from a variety of perspectives, including the inventor and patent examiner alike. She is also committed to writing patents and rendering long-term advice that furthers each client’s business objectives and is resilient to competitor attacks.
Large, middle market and established companies appreciate that when Rose is at the helm, their goals remain a top priority and their work product is consistently outstanding. In the event a problem should arise, Rose addresses and resolves the issue immediately and with a focus on what the client needs. In addition to experience and technical know-how, clients also value that Rose is sensitive to their budgetary requirements and keep costs under control. Because Rose believes in collaboration, she creates a working environment where clients can offer candid feedback at any point. Rose’s honest and direct communication style allow her to establish immediate credibility and enduring trust. Rose seeks to perpetually earn her client’s respect and their complete satisfaction regarding the legal services she provides.
Prior to joining the firm, Rose worked at Exxon Research and Engineering Company, where she held positions as a Chemist in fuels technology and as an Information Scientist specializing in chemical patent information. Rose’s first-hand experience working in house allows her to understand the many pressures her clients face. Her education, business acumen, training and skills as a chemist and scientist enable Rose to work seamlessly with inventors, scientists, in-house counsel, executives and entrepreneurs alike.
“Chapter 8, Chemical and Pharmaceutical Patents” in “Drafting Patents for Litigation and Licensing”, Bradley C. Wright, Editor-in-Chief, Banner & Witcoff, Ltd.
“Chapter 19, United States” in “International Pharmaceutical Law and Practice”, Dr. MM Kleyn & LJ van Wyk, General Editors, LexisNexis.
"Patent-Eligible Subject Matter and Healthy Aging Technology," Medical Device and Diagnostics Industry (MD+DI) (June 4, 2017).
"Intellectual Property Law: What Nutraceutical Companies Should Know," Rose Thiessen and Samantha Markley, Nutraceuticals World (June 13, 2016).
“Recent legal developments from a nanotechnology perspective”, Rose Thiessen and Vladimir Lozan, Nanotechnology Reviews, Vol. 1, No. 3, 2012, 289-292.
Speeches & Seminars
Panelist, “Career Transitions that Build Success”, Healthcare Businesswomen’s Association, San Diego Chapter, February 2016.
Presenter, “Why is Intellectual Property Important?”, Introduction to Technology Commercialization Workshop, University of California, San Diego, April 2016.
Panelist, “Practice before the PTAB in IPRs and CMBRs”, Stanford Symposium on the PTO and the Courts, Stanford University, April 2015.
Presenter “Practical Implications of the Leahy-Smith America Invents Act: Avoiding Prior Art Pitfalls and Other Traps for the Unwary”, American Chemical Society – Western Regional Meeting, Santa Clara, CA, October 2013.
Panelist, "Important Developments in Intellectual Property and How They Impact Your Business," IP Impact - Silicon Valley Seminar, September 2013 (Palo Alto, CA)
Panelist, "Patenting the Unpatentable: Claim Drafting After Prometheus", IP Impact - San Diego Seminar, August 2012 (San Diego, CA)
Moderator, "Procedures, Pitfalls and Costs: Best Practices for Securing Foreign Patent Protection," IP Impact - Northern Virginia Seminar, May 2012 (McLean, VA)
Presenter, “Overview of the America Invents Act”, San Diego Section of the American Society of Mechanical Engineers, March 2012.
Presenter, "How to Jump Start Your Company’s Patent Program," IP Impact - Northern Virginia Seminar, September 2011 (Falls Church, VA)
Presenter, "How to Jump Start Your Company’s Patent Program," IP Impact - Research Triangle Park Seminar, August 2011 (Durham, NC)
Presenter, "IP Cost Management," IP Impact - San Diego Seminar, August 2011 (San Diego, CA)
Panelist, "IP cost management — how to get the most from your time and IP dollars, without sacrificing quality", IP Impact - Silicon Valley Seminar, July 2010 (Menlo Park, CA)